Science Explorer Interactive view Map

GlaxoSmithKline (United States)

In research, GlaxoSmithKline (United States) stands highest in Medicine (#2,975 of 10,443 worldwide), Life Sciences (#2,223 of 7,800 worldwide) and Health Sciences (#4,090 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Immunology and Microbiology and Epidemiology — Immunology and Microbiology is 7.1× its share of world research.

World rank, 2022–2025
#4,744
of 28,054 · #1,846 all time
Rank in United States
#659
of 4,192
Research works
4.4k
▼ 4% vs 2013–17
Citations
198k
45.3 per fractional work
Top-10% rate
16.7%
record average 16.5%
Open access
39%
world 28%

What is GlaxoSmithKline (United States) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #2,975 of 10,443 14.9%290 #1035
Life SciencesDomain #2,223 of 7,800 21.8%117 #713
Health SciencesDomain #4,090 of 11,982 14.8%299 #1272
Biochemistry, Genetics and Molecular BiologyField #2,578 of 3,579 20.0%68 #901

Each strip is that field’s whole ranked pool, with the notch where GlaxoSmithKline (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Medicine#1,035 #2,975
  2. Life Sciences#713 #2,223
  3. Health Sciences#1,272 #4,090
  4. Biochemistry, Genetics and Molecular Biology#901 #2,578
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does GlaxoSmithKline (United States) specialise in?

Where its research is concentrated relative to its size: Immunology and Microbiology takes 7.1× the share of its output that it takes of world research.

  1. Immunology and MicrobiologyField · 34.6 works7.1×
  2. EpidemiologySubfield · 47.5 works7.0×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.15× its world share, 4 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.66× its world share, 68 worksBiochemistry, Geneti…Immunology and Microbiology: 7.12× its world share, 35 worksImmunology and Micro…Neuroscience: 0.60× its world share, 5 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.59× its world share, 6 worksPharmacology, Toxico…Chemical Engineering: 0.21× its world share, 0 worksChemical EngineeringChemistry: 1.61× its world share, 12 worksChemistryComputer Science: 0.13× its world share, 5 worksComputer ScienceEarth and Planetary Sciences: 0.02× its world share, 0 worksEarth and Planetary …Energy: 0.05× its world share, 0 worksEnergyEngineering: 0.17× its world share, 13 worksEngineeringEnvironmental Science: 0.11× its world share, 3 worksEnvironmental ScienceMaterials Science: 0.13× its world share, 2 worksMaterials ScienceMathematics: 1.06× its world share, 6 worksMathematicsPhysics and Astronomy: 0.07× its world share, 1 worksPhysics and AstronomyHealth Professions: 0.47× its world share, 6 worksHealth ProfessionsMedicine: 3.12× its world share, 290 worksMedicineNursing: 0.18× its world share, 0 worksNursingVeterinary: 3.43× its world share, 2 worksVeterinaryDecision Sciences: 0.68× its world share, 3 worksDecision SciencesEconomics, Econometrics and Finance: 1.24× its world share, 13 worksEconomics, Econometr…Psychology: 0.15× its world share, 2 worksPsychologySocial Sciences: 0.11× its world share, 7 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 7.1×. Every wedge is a field page.

Who are the top researchers at GlaxoSmithKline (United States)?

Ranked on the composite score, Vincent Mooser, Rafael Alfonso‐Cristancho and John Bertin lead among researchers whose main affiliation is GlaxoSmithKline (United States).

  1. 1 Vincent Mooser United States · #7,849 worldwide 1.5k citations · 53 works
  2. 2 Rafael Alfonso‐Cristancho United States · #30,580 worldwide 821 citations · 34 works
  3. 3 John Bertin United States · #46,913 worldwide 455 citations · 30 works
  4. 4 Axel Hoos United States · #51,441 worldwide 285 citations · 37 works
  5. 5 Catherine Ellis United States · #64,630 worldwide 316 citations · 28 works
  6. 6 Philip A. Harris United States · #66,879 worldwide 215 citations · 40 works
  7. 7 Ruth Tal‐Singer United States · #69,449 worldwide 211 citations · 54 works
  8. 8 Peter J. Gough United States · #160,020 worldwide 308 citations · 19 works
  9. 9 Deborah A. Smith United States · #161,066 worldwide 156 citations · 36 works
  10. 10 Tona M. Gilmer United States · #164,989 worldwide 197 citations · 27 works
All ranked researchers at GlaxoSmithKline (United States)

Which keywords describe research at GlaxoSmithKline (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Inflammation, Immune Response, Treatment, Vaccine, Diagnosis, Pathogenesis and Immunology.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology90▲ 4.7×67 topics
  2. Inflammation40▲ 3.9×45 topics
  3. Treatment32▲ 5.5×28 topics
  4. Immune Response28▲ 10×15 topics
  5. Vaccine27▲ 14×11 topics
  6. Diagnosis24▲ 5.4×21 topics
  7. Management20▲ 5.3×11 topics
  8. Pathogenesis20▲ 8.1×16 topics
  9. Genetics20▲ 5.8×8 topics
  10. Chemotherapy19▲ 5.7×16 topics
  11. Quality of Life19▲ 2.7×18 topics
  12. Immunology18▲ 34×2 topics
  13. Asthma17▲ 37×2 topics
  14. Clinical Trials17▲ 5.3×12 topics
  15. Global Burden17▲ 6.6×10 topics
  16. Allergic Diseases16▲ 58×1 topic
  17. Eosinophils16▲ 58×1 topic
  18. Antimicrobial Resistance16▲ 17×6 topics
  19. Antiretroviral Therapy16▲ 20×5 topics
  20. Treatment Guidelines15▲ 15×4 topics
  21. Biomarkers15▲ 4.6×14 topics
  22. Respiratory14▲ 31×2 topics
  23. Immunity14▲ 7.0×9 topics
  24. Vaccine Development12▲ 10×8 topics
  25. COPD12▲ 37×1 topic
  26. spirometry12▲ 37×1 topic
  27. Autoantibodies12▲ 10×6 topics
  28. Monoclonal Antibodies12▲ 27×3 topics
  29. Glycosylation10▲ 19×3 topics
  30. Microbiome10▲ 16×2 topics
  31. Catheter-Associated Infections10▲ 64×1 topic
  32. Prevention Strategies10▲ 21×2 topics
  33. Urinary Tract Infections10▲ 51×1 topic
  34. Drug Resistance9▲ 6.6×6 topics
  35. JAK2 Mutation9▲ 78×1 topic
  36. Myelofibrosis9▲ 78×1 topic
  37. Herpes Zoster9▲ 61×1 topic
  38. Herpesviruses9▲ 61×1 topic
  39. Therapeutic Antibodies8▲ 25×2 topics
  40. Nanomedicine8▲ 22×2 topics

Which research topics does GlaxoSmithKline (United States) publish most on?

By volume in 2022–2025: Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Urinary Tract Infections Management and Myeloproliferative Neoplasms: Diagnosis and Treatment.

  1. 1 Asthma and respiratory diseases Physiology 16 works
  2. 2 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 12 works
  3. 3 Urinary Tract Infections Management Epidemiology 10 works
  4. 4 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 9 works
  5. 5 Herpesvirus Infections and Treatments Epidemiology 9 works
  6. 6 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 8 works
  7. 7 Respiratory viral infections research Epidemiology 8 works
  8. 8 Multiple Myeloma Research and Treatments Hematology 7 works
  9. 9 Ovarian cancer diagnosis and treatment Reproductive Medicine 7 works
  10. 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 6 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.4%not open60.6%

World: 28% of research is openly available.

with international co-authors37.8%domestic only62.2%

World: 19% is written across borders.

How has GlaxoSmithKline (United States)'s research output changed?

Output in 2018–2022 was 4% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Philadelphia

All research institutions in Philadelphia

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.